Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · IPHC 2027

HIV/AIDS at IPHC 2027

Part of the IPHC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the HIV/AIDS Session

HIV/AIDS, caused by the human immunodeficiency virus (HIV), remains a critical public health challenge. This viral infection attacks the immune system, gradually weakening its ability to fight off infections and diseases. HIV is primarily transmitted through unprotected sexual intercourse, sharing of contaminated needles, and from an infected mother to her child during childbirth or breastfeeding, as well as through blood transfusions and organ transplantations with infected blood or tissues. The progression of HIV involves distinct stages, with the initial infection often presenting flu-like symptoms. However, individuals can remain asymptomatic for an extended period. Without proper medical intervention, HIV can advance to acquired immunodeficiency syndrome (AIDS), characterized by a severe depletion of immune cells, leaving the individual susceptible to opportunistic infections and certain cancers. Preventive measures play a crucial role in controlling the spread of HIV. These include promoting safe sex practices, ensuring the use of sterile needles, and implementing strategies to prevent mother-to-child transmission. Antiretroviral therapy (ART) is a cornerstone of HIV management, helping control viral replication and allowing individuals with HIV to lead healthier lives. Additionally, ART significantly reduces the risk of transmitting the virus to others. While there is no cure for HIV/AIDS, advancements in medical treatments have transformed the prognosis for those living with the virus. Early detection, access to healthcare, and adherence to treatment regimens have become pivotal in managing the disease and preventing its progression to AIDS. Global efforts in HIV/AIDS awareness, prevention, and treatment continue to make significant strides. Destigmatizing the condition remains a priority to encourage testing, promote open dialogue, and ensure a supportive environment for those affected by HIV/AIDS. The goal is to create a world where individuals living with HIV can access proper care, lead fulfilling lives, and contribute to the broader efforts to curb the spread of the virus.

Topics Covered in HIV/AIDS

Topic 01

HIV testing and early diagnosis

Topic 02

Antiretroviral therapy and treatment adherence

Topic 03

Prevention of mother-to-child transmission

Topic 04

Pre-exposure prophylaxis and combination prevention

Topic 05

Opportunistic infections and coinfection management

Topic 06

HIV stigma, disclosure and support services

Featured Speakers — HIV/AIDS 2027

Browse all speakers →

Recent Research Presented at HIV/AIDS Sessions

Related Scientific Sessions at IPHC 2027

Why Attend the HIV/AIDS Conference 2027

Earn CPD Credit

Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.

Present Your Research

Oral and poster slots for original HIV/AIDS work, reviewed by the scientific committee.

Network Globally

Meet public health researchers, educators, and policy leaders from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping HIV/AIDS research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join IPHC 2027 for the HIV/AIDS track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

HIV/AIDS Conference 2027 — FAQs

What is the HIV/AIDS track at IPHC 2027?

The HIV/AIDS track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in HIV/AIDS. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the HIV/AIDS sessions?

Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in HIV/AIDS are all welcome — whether presenting or attending.

Can I present my research in the HIV/AIDS track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for HIV/AIDS sessions?

Yes. IPHC 2027 is a hybrid conference — attend the HIV/AIDS track in person in Singapore or join live online, with on-demand access afterward.

Join the IPHC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us